BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Okan G, Yaylaci S, Peker O, Kaymakoglu S, Saruc M. Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus. World J Gastroenterol 2008; 14(29): 4697-4700 [PMID: 18698687 DOI: 10.3748/wjg.14.4697]
URL: https://www.wjgnet.com/1007-9327/full/v14/i29/4697.htm
Number Citing Articles
1
Wan-Chen Lin, Tyng-Shiuan Hsieh, Chia-Yu Chu. Case report: Development of vanishing bile duct syndrome in Stevens-Johnson syndrome complicated by hemophagocytic lymphohistiocytosisFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.975754
2
Abimbola Adike, Maxwell L. Smith, Amy Chervenak, Hugo E. Vargas. Hydroxycut-related Vanishing Bile Duct SyndromeClinical Gastroenterology and Hepatology 2017; 15(1): 142 doi: 10.1016/j.cgh.2016.04.028
3
Marianne Lerch, Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Thomas Harr. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisClinical Reviews in Allergy & Immunology 2018; 54(1): 147 doi: 10.1007/s12016-017-8654-z
4
Eran Israeli, Charles N. Bernstein. Yamada' s Textbook of Gastroenterology2015; : 2399 doi: 10.1002/9781118512074.ch124
5
Kosuke Sumida, Kazufumi Dohmen, Shinichi Aishima, Sho Iwasaka, Satomi Hisamoto, Yukiko Harada, Noriko Miyake, Nobuyuki Shimono, Shinji Shimoda. A case of vanishing bile duct syndrome complicated with toxic epidermal necrolysis performed liver biopsy three times subsequentlyKanzo 2013; 54(1): 67 doi: 10.2957/kanzo.54.67
6
Manuela G. Neuman, Lawrence B. Cohen, Radu M. Nanau. Quinolones-induced hypersensitivity reactionsClinical Biochemistry 2015; 48(10-11): 716 doi: 10.1016/j.clinbiochem.2015.04.006
7
Naomi Gronich, David Maman, Nili Stein, Walid Saliba. Culprit Medications and Risk Factors Associated with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Population-Based Nested Case–Control StudyAmerican Journal of Clinical Dermatology 2022; 23(2): 257 doi: 10.1007/s40257-021-00661-0
8
Ananth Kashyap, Sahana Sreenivasan, Asha K Rajan, Muhammed Rashid, Manik Chhabra. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studiesJournal of Basic and Clinical Physiology and Pharmacology 2022; 33(3): 327 doi: 10.1515/jbcpp-2020-0115
9
Jianglin Wang, Shengfeng Wang, Cuifang Wu, Zhenzhen Deng. Antibiotic-associated vanishing bile duct syndrome: a real-world retrospective and pharmacovigilance database analysisInfection 2023;  doi: 10.1007/s15010-023-02132-6
10
J. A. Jaffey. Canine intrahepatic biliary diseaseJournal of Small Animal Practice 2022; 63(3): 167 doi: 10.1111/jsap.13433
11
Juricic Danica, Hrstic Irena, Radic Davor, Skegro Mate, Coric Marijana, Vucelic Boris, Francetic Igor. Vanishing Bile Duct Syndrome Associated with Azithromycin in a 62‐Year‐Old ManBasic & Clinical Pharmacology & Toxicology 2010; 106(1): 62 doi: 10.1111/j.1742-7843.2009.00474.x
12
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic SclerosisACG Case Reports Journal 2018; 5(12): e951 doi: 10.14309/02075970-201805120-00011
13
Paul Wasuwanich, Hassan Choudry, Joshua M. So, Sarah Lowry, Wikrom Karnsakul. Vanishing bile duct syndrome after drug-induced liver injuryClinics and Research in Hepatology and Gastroenterology 2022; 46(9): 102015 doi: 10.1016/j.clinre.2022.102015
14
Manmeet S. Padda, Mayra Sanchez, Abbasi J. Akhtar, James L. Boyer. Drug-induced cholestasisHepatology 2011; 53(4): 1377 doi: 10.1002/hep.24229
15
Anna Licata, Claudia Randazzo, Ilaria Morreale, Giuseppe Butera, Natale D’Alessandro, Antonio Craxì. Fluoroquinolone-induced liver injury: three new cases and a review of the literatureEuropean Journal of Clinical Pharmacology 2012; 68(5): 525 doi: 10.1007/s00228-011-1201-6
16
Hye-young Kim, Hea Kyoung Yang, Seong Heon Kim, Jae Hong Park. Ibuprofen Associated Acute Vanishing Bile Duct Syndrome and Toxic Epidermal Necrolysis in an InfantYonsei Medical Journal 2014; 55(3): 834 doi: 10.3349/ymj.2014.55.3.834
17
Jason C. White, Stephanie Appleman. Infliximab/Plasmapheresis in Vanishing Bile Duct Syndrome Secondary to Toxic Epidermal NecrolysisPediatrics 2014; 134(4): e1194 doi: 10.1542/peds.2013-2239
18
Marianne Lerch, Thomas Harr. Cutaneous Drug Hypersensitivity2022; : 29 doi: 10.1007/978-3-030-82743-4_4
19
Fumitaka Mizuno, Norihiro Imai, Kazushi Yasuda, Shinya Yokoyama, Kenta Yamamoto, Takanori Ito, Yoji Ishizu, Takashi Honda, Masatoshi Ishigami, Hiroki Kawashima. Successful Treatment with Steroids in a Patient with Vanishing Bile Duct Syndrome and Acute Tubular NecrosisInternal Medicine 2024; 63(1): 57 doi: 10.2169/internalmedicine.1826-23
20
Daniel Sedhom, Amanda Herrmann, Melroy DʼSouza, Billie Fyfe, Francisco Zaldana, Naomi Schlesinger, Vinod Rustgi. Vanishing Bile Duct Syndrome in a Patient with Uterine Cancer and Paraneoplastic Systemic SclerosisACG Case Reports Journal 2018; 5(1): e95 doi: 10.14309/02075970-201805000-00095
21
Thomas H. Tung. Tacrolimus (FK506): Safety and Applications in Reconstructive SurgeryHAND 2010; 5(1): 1 doi: 10.1007/s11552-009-9193-8
22
Kento Shionoya, Masahiro Kobayashi, Makoto Kako, Sakue Masuda, Makomo Makazu, Kazuya Koizumi. A Case of Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct SyndromeInternal Medicine 2024;  doi: 10.2169/internalmedicine.2427-23
23
Sahand Rahnama-Moghadam, Hans L. Tillmann. DILI Associated with Skin ReactionsCurrent Hepatology Reports 2018; 17(3): 225 doi: 10.1007/s11901-018-0414-x
24
Xi Chen, Cheng Zhang, Hua Wang, Juan Xu, Zi-Hao Duan, Ying Zhang, Tao Yu, Wei Wei, De-Xiang Xu, Jian-Ming Xu. Altered integrity and decreased expression of hepatocyte tight junctions in rifampicin-induced cholestasis in miceToxicology and Applied Pharmacology 2009; 240(1): 26 doi: 10.1016/j.taap.2009.06.022
25
Current World LiteratureCurrent Opinion in Pediatrics 2009; 21(4): 553 doi: 10.1097/MOP.0b013e3283300b10
26
Michael J Eiswerth, Matthew A Heckroth, Ali Ismail, Dibson D Gondim, Ryan Kaufman. Infliximab-Induced Vanishing Bile Duct SyndromeCureus 2022;  doi: 10.7759/cureus.21940
27
H.Y. Lee, S.A. Walsh, D. Creamer. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-upBritish Journal of Dermatology 2017; 177(4): 924 doi: 10.1111/bjd.15360
28
Fernando Bessone, Nelia Hernández, Mario Tanno, Marcelo G. Roma. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and TherapeuticsSeminars in Liver Disease 2021; 41(03): 331 doi: 10.1055/s-0041-1729972
29
Jose M. Pinazo-Bandera, Juan Pedro Toro-Ortiz, Raúl J. Andrade, Miren García-Cortés. Drug-induced cholestasis: causative agents and challenges in diagnosis and managementExploration of Digestive Diseases 2023; 2(5): 202 doi: 10.37349/edd.2023.00027
30
Soraya Salas-Silva, Arturo Simoni-Nieves, Jocelyn Lopez-Ramirez, Leticia Bucio, Luis E. Gómez-Quiroz, María Concepción Gutiérrez-Ruiz, Marcelo G. Roma. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategiesLife Sciences 2019; 218: 324 doi: 10.1016/j.lfs.2018.12.044
31
Ahmed Hashim, Ashley Barnabas, Rosa Miquel, Kosh Agarwal. Successful liver transplantation for drug-induced vanishing bile duct syndromeBMJ Case Reports 2020; 13(1): e233052 doi: 10.1136/bcr-2019-233052
32
Kyrillos Faragalla, Helena Lau, Hanlin L. Wang, Jimin Liu. Cloxacillin‐induced acute vanishing bile duct syndrome: A case study and literature reviewBritish Journal of Clinical Pharmacology 2022; 88(10): 4633 doi: 10.1111/bcp.15445